Pharmaceutical composition comprising proteins and/or polypeptides and colloidal particles

Details for Australian Patent Application No. 2004229253 (hide)

Owner Opperbas Holding B.V.

Inventors Baru, Moshe; Carmel-Goren, Lea

Agent Davies Collison Cave

Pub. Number AU-B-2004229253

PCT Pub. Number WO2004/091723

Priority 60/462,701 15.04.03 US

Filing date 15 April 2004

Wipo publication date 28 October 2004

Acceptance publication date 5 November 2009

International Classifications

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61K 9/127 (2006.01) Medicinal preparations characterised by special physical form - Liposomes

A61K 38/19 (2006.01) Medicinal preparations containing peptides - Cytokines

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

A61K 38/26 (2006.01) Medicinal preparations containing peptides - Glucagons

A61K 38/37 (2006.01) Medicinal preparations containing peptides

A61K 38/48 (2006.01) Medicinal preparations containing peptides

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

27 October 2005 PCT application entered the National Phase

  PCT publication WO2004/091723 Priority application(s): WO2004/091723

5 November 2009 Application Accepted

  Published as AU-B-2004229253

4 March 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004229256-Use of L-carnitine for the treatment of cardiovascular diseases

2004229237-Use of SLURP-1 for treating diseases related to acetylcholine receptors dysfunction